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In this issue of Eurointervention two interesting image reports are describing the 
OCT appearance of restenotic tissue of sirolimus-eluting stents and both are 
referring to the “black hole” phenomenon, that was first described as an 
observation in IVUS-studies of restenotic tissue of patients after radioactive stent 
implantation or brachytherapy (1, 2).  In some of these patients echolucent 
restenotic tissue was detected with a remarkable homogeneous black 
appearance without backscatter and was termed “black hole” (1).  These lesions 
were clearly distinguishable from  echoreflective neointimal hyperplasia (1). 
Atherectomy samples from these lesions revealed a hypocellular matrix (likely at 
least partly due to cell death) rich in proteoglycan and poor in mature connective 
tissue elements, such as  collagen-matrix and elastin (1, 3).   
 
Later, a “black hole” phenomenon was also described in restenotic tissue of 
some patients after sirolimus-eluting stent implantation (4).  In patients who had a 
sirolimus-eluting stent implanted after failure of previous intracoronary 
brachytherapy black holes were rather frequently observed by IVUS analysis 
(approximately 20 % of patients)(5).  In patients without a previous brachytherapy 
the black hole phenomenon was observed more rarely.  An analysis of IVUS 
exams in 102 consecutive patients with sirolimus-eluting stent restenosis 
reported a “black hole” in 8 patients (6).  Recent reports from a histological 
analysis of atherectomy samples of restenotic tissue from sirolimus-eluting stents 
with “black hole” IVUS-appearance suggested that organized thrombotic material 
with fibrin can also cause such an echolucent image phenomenon after 
sirolimus-eluting stent implantation (7, 8). Recent studies have suggested that 
low OCT-signal intensity can be related to different tissue composition after DES 
implantation:   
 
Low OCT/OFDI signal intensity due to proteoglycan-rich/collagen-matrix 
poor restenotic tissue or fibrin-rich thrombus formation: The two cases 
reported in the present issue of Eurointervention are referring to the “black hole” 
phenomenon and are suggesting that the observed low OCT signal-intensity in 
areas of restenotic tissue is related to cell death and low amounts of organized 
mature connective tissue elements, such as collagen matrix (although no 
histological analysis has been performed).   The case reported by Kurita et al., 
describes the OCT appearance of a transient black hole phenomenon by IVUS 
two months after sirolimus-eluting stent implantation (Kurita et al., 
Eurointervention 2012).  OCT revealed a layered structure with an inner high 
signal intensity layer and outer layers of low OCT signal intensity. Of note, a 
previous report has described the histological examination (after atherectomy) of 
two sirolimus-eluting stent restenotic lesions with low OCT signal intensity and 
has suggested that this can be due to both, myxoid tissue or fibrin-rich thrombus 
formation (9).  However, myxoid tissue appeared as a layered structure by OCT 
whereas another case with fibrin-rich thrombus formation had a more irregular, 
patchy structural OCT appearance, supporting the possibility that the observation 
in the present case may rather represent myxoid tissue.   
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In the case reported by Linares et al. OCT findings of a patient are presented 
who had restenosis two month after paclitaxel-coated balloon angioplasty of 
sirolimus-eluting stent restenosis (Linares et al., Eurointervention 2012),   
revealing large homogenous-appearing elliptic areas with low OCT signal-
intensity.  The shape of the lesions strongly reminds of the “black hole” images 
using IVUS.  As described in this editorial, several different restenotic tissues can 
appear with low OCT signal-intensity.  However, the regular border and structure 
of the low OCT signal-intensity areas of this case raise the possibility that the 
restenotic tissue with OCT “black hole” appearance may result from cell death 
and low amounts of organized mature connective tissue elements. 
 
Low OCT/OFDI signal intensity of fibrin accumulation surrounding stent 
struts:  Notably, several recent studies have described that fibrin accumulation 
surrounding stent struts appears by OCT/OFDI with a lower signal intensity as 
compared to neointima without fibrin accumulation (10, 11).  We have observed 
in a study at different time points after porcine coronary stent implantation that 
fibrin-rich tissue as detected early after stent implantation and confirmed by 
electron microscopy had a substantially lower OCT signal-intensity when 
compared to neointima-covered stent struts later after implantation, that were 
covered by smooth muscle cell-rich tissue with extracellular matrix containing 
collagens (10).  Another recent study has compared the OCT/OFDI and 
histological appearance of tissue surrounding stent struts from human stents at 
autopsy (11).  A clear difference in the OFDI signal intensity was observed 
between fibrin accumulation and normal neointima tissue, and signal attenuation 
was greater for fibrin (11).  Interestingly, we as well as Nakano et al. have 
observed that the luminal surface appears mostly irregular by OCT when stent 
struts are covered by fibrin accumulation as opposed to neointima (10, 11). 
suggesting that additional structural features may help in the characterization of 
tissue with low OCT signal-intensity.   
 
Low OCT/OFDI signal intensity of in-stent neoatherosclerosis:  In-stent 
neoatherosclerosis represents another possible cause of late restenotic tissue 
with low OCT signal intensity.  OCT examination has recently supported the 
concept that neoatherosclerosis may contribute to late drug-eluting stent 
restenosis and may contribute to clinical events in these patients, such as by 
neointimal rupture (12), representing another possible mechanism in addition to 
impaired stent healing/coverage resulting in very late stent thrombosis (13).   The 
frequency of neoatherosclerotic lesions reported by OCT was higher as 
compared to autopsy histological studies (14).  A potential overestimation of in-
stent neoatherosclerosis by OCT can therefore not be excluded. For example, 
the distinction between fibrin accumulation and a lipid core may be challenging 
(15), and more experience and validation studies will be needed.   
 
In summary, high-resolution of OCT/OFDI can give us further interesting insights 
into the vascular response after stent implantation.  The relation between 
OCT/OFDI characteristics, including signal intensity, and the underlying tissue 
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composition is an area requiring further  investigation.  Large OCT registries will 
be required to gain more insights into the OCT appearance of different types of 
restenotic tissues and there potential clinical implications. 
 
 
 
 
 
 
Figure legend 
There are several intraluminal restenotic tissues that can appear with a low OCT 
signal intensity, including proteoglycan-rich/collagen-poor tissue (such as the 
“black hole” appearance after intracoronary radiation), fibrin accumulation, fibrin-
rich organized thrombus, in-stent neoatherosclerosis and excessive 
inflammation.  Therefore the OCT signal intensity alone is not sufficient to 
distinguish between these different restenotic tissues.  However, there are 
additional characteristics or associated signals of these different tissues that may 
aid in their distinction, some of which are noted in the figure.  
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